Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
Cardiomyocyte Regulation of Systemic Lipid Metabolism by the Apolipoprotein B-Containing Lipoproteins in Drosophila.
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
Harvey murine sarcoma virus
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013 Oct 10; 369(15):1406-15.
View in:
PubMed
subject areas
Aged
Anticoagulants
Double-Blind Method
Drug Administration Schedule
Enoxaparin
Female
Hemorrhage
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Pulmonary Embolism
Venous Thromboembolism
Warfarin
authors with profiles
Gary E Raskob